DiogenX

📍 Marseille, France🗓 Founded 2020👥 14 employees💰 Last funded Jan 2020
Biotechnology🌐 diogenx.com
Website LinkedIn
DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world. Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits. DiogenX is headquartered in Marseille, with labs in Nice (France).
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in DiogenX?
DiogenX has 1 investors on record on gritt.io, including 1 early-stage backers.
When did DiogenX last raise funding?
The most recent investment in DiogenX recorded on gritt.io was in January 2020.
When was DiogenX founded?
DiogenX was founded in 2020.
What industry is DiogenX in?
DiogenX operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is DiogenX based?
DiogenX is headquartered in Marseille, France.